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Background 
 
Although standard glucose-based
oral rehydration therapy corrects the dehydration
caused by cholera, it does not reduce the diarrhea.
Short-chain fatty acids, which are produced in the
colon from nonabsorbed carbohydrates, enhance so-
dium absorption. We conducted a study to determine
the effects of an orally administered, nonabsorbed
starch (i.e., one resistant to digestion by amylase) on
fecal fluid loss and the duration of diarrhea in pa-
tients with cholera.
 
Methods 
 
We randomly assigned 48 adolescents
and adults with cholera to treatment with standard oral
rehydration therapy (16 patients), standard therapy
and 50 g of rice flour per liter of oral rehydration solu-
tion (16 patients), or standard therapy and 50 g of high-
amylose maize starch, an amylase-resistant starch,
per liter of oral rehydration solution (16 patients). The
primary end points were fecal weight (for every 12-
hour period during the first 48 hours after enrollment)
and the length of time to the first formed stool.
 
Results
 
The mean (±SD) fecal weights in the peri-
ods 12 to 24 hours, 24 to 36 hours, and 36 to 48 hours
after enrollment were significantly lower in the re-
sistant-starch group (2206±1158 g, 1810±1018 g, and
985±668 g) than in the standard-therapy group (3251±
766 g, 2621±1149 g, and 2498±1080 g; P=0.01, P=
0.04, and P=0.001, respectively). From 36 to 48 hours
after enrollment, fecal weight was also significantly
lower with the resistant-starch therapy than with the
rice-flour therapy (985±668 g vs. 1790±866 g, P=0.01).
The mean duration of diarrhea was significantly short-
er with the resistant-starch therapy (56.7±18.6 hours)
than with standard therapy alone (90.9±29.8 hours,
P=0.001) or the rice-flour therapy (70.8±20.2 hours,
P=0.05). Fecal excretion of starch was higher with
the resistant-starch therapy (32.6±30.4) than with the
standard therapy (11.7±4.1 g, P=0.002) or the rice-
flour therapy (15.1±8.4 g, P=0.01).
 
Conclusions
 
The addition of a resistant starch to
oral rehydration solution reduces fecal fluid loss and
shortens the duration of diarrhea in adolescents and
adults with cholera. (N Engl J Med 2000;342:308-13.)
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IARRHEAL disease is one of the two
main causes of death in children in devel-
oping countries, claiming the lives of more
than 3 million children every year.
 
1
 
 In con-
trolled studies, oral rehydration therapy is very effec-
tive in correcting dehydration and reducing mortality.
 
2
 
Glucose and other solutes stimulate the absorption
of sodium from the small intestine, a process that is
D
 
not inhibited by cyclic nucleotides that modify proc-
esses for the active transport of sodium and chloride.
 
3
 
The rate of use of oral rehydration therapy has re-
mained low in both developing and developed coun-
tries, even though it has been publicized through
health-education efforts.
 
4-7
 
 In developing countries,
several factors are responsible for the poor acceptance
of oral rehydration therapy. There is a perception that
oral rehydration is not effective because it does not
reduce the manifestations of diarrhea, such as the loss
of fluid in feces, or the duration of diarrheal illness.
 
8,9
 
The glucose-based oral rehydration solution recom-
mended by the World Health Organization may, par-
adoxically, increase fecal fluid loss.
 
10
 
 Because of these
limitations, there has been a substantial impetus to
develop a better oral rehydration therapy.
 
11
 
The colon absorbs sodium against steep electro-
chemical gradients and can absorb up to about 5 li-
ters of fluid daily.
 
12
 
 The absorptive capacity of the co-
lon can compensate, to a considerable extent, for the
secretion of fluid from the small intestine in diarrhe-
al disease.
 
13
 
 In cholera, in addition to such secretion,
there is decreased absorption of fluid in the large in-
testine,
 
14
 
 a phenomenon that can be reversed by short-
chain fatty acids.
 
15
 
 Short-chain fatty acids are pro-
duced in the colon by the bacterial fermentation of
unabsorbed carbohydrates.
 
16
 
 Starch that is resistant to
digestion by amylases in the small intestine (amylase-
resistant starch) is found in small quantities in many
cereals and is a good substrate for colonic fermenta-
tion.
 
16,17
 
 High-amylose maize starch, obtained from
a specific variety of corn, is rich in resistant starch
that is type 2, a classification based on the structure
and conformation of native starch molecules.
 
17
 
 When
it is eaten uncooked, 50 to 70 percent of the starch
is not digested in the small intestine.
 
18
 
 In healthy hu-
mans, high-amylose maize starch is fermented and
converted to short-chain fatty acids in the colon.
 
18,19
 
Because amylase-resistant starch usually is ferment-
ed in the colon and is converted to short-chain fatty
acids, and because the stimulation of sodium absorp-
tion by short-chain fatty acids has not been altered
by mucosal cyclic AMP experimentally,
 
20
 
 we hypoth-
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esized that adding amylase-resistant starch to the treat-
ment given to patients with cholera would result in re-
duced fecal volume and a shorter duration of diarrhea.
We undertook the present study to test this hypothesis.
 
METHODS
 
Patients
 
Forty-eight consecutive adolescent or adult patients (age range,
14 to 58 years) with cholera who were admitted to the Christian
Medical College and Hospital in Vellore, India, between May 1994
and July 1996 entered the study. Patients were included if they
had acute, watery diarrheal illness of less than 72 hours’ duration
and were positive for organisms associated with cholera by hang-
ing-drop examination of the stool. (In hanging-drop examination,
a wet mount of stool under dark-field illumination is examined
for organisms with a motility pattern characteristic of vibrios.) Pa-
tients who had previously received antibiotic therapy and those with
severe systemic illness were excluded from the study.
 
Study Protocol
 
We randomly assigned patients to receive one of three thera-
pies: a glucose-based oral rehydration solution (World Health Or-
ganization formula B), a glucose-based oral rehydration solution
to which 50 g of rice flour was added per liter of solution, or a
glucose-based oral rehydration solution to which 50 g of high-
amylose maize starch was added per liter of solution (amylase-
resistant starch). The randomization involved the use of permut-
ed blocks in each of which six patients were randomly assigned to
the three treatment groups so that two patients were in each treat-
ment group. We then chose a new block of six patients, so that the
sequence of assignment to the treatment groups was different from
the previous block, until we had assigned eight blocks of patients.
Both the rice flour (obtained commercially) and the amylase-
resistant starch (provided by Starch Australasia, Sydney, Australia)
formed finely dispersed suspensions, which were ingested imme-
diately after preparation. The glucose-based oral rehydration so-
lution was packaged in bags, each of which could be reconstituted
in 200 ml of water. The amylase-resistant starch and rice flour were
added in 10-g quantities, uncooked, to 200 ml of reconstituted
oral rehydration solution just before consumption. The osmolality
of the three solutions was similar and averaged 327 mOsm per
kilogram as measured by a vapor-pressure osmometer (Wescor, Lo-
gan, Utah). All patients provided oral informed consent. The study
protocol was approved by the research committee of the Chris-
tian Medical College and Hospital.
Patients were treated with oral rehydration solution (alone or
with rice flour or amylase-resistant starch added) according to
World Health Organization treatment plan B, which is used for
the management of mild to moderate dehydration and involves
the administration of oral rehydration solution at a rate of 75 ml
per kilogram of body weight (to a maximum of 4 liters) in the
first four hours. Rice flour, a common constituent of cereal-based
oral rehydration solutions, contains both starch and other com-
plex carbohydrates. Because of the nature of the suspension formed
with amylase-resistant starch, patients could not be made com-
pletely unaware of the treatment they received. However, rice flour
and amylase-resistant starch formed suspensions of similar appear-
ance, and patients and their care givers did not know whether the
patients were assigned to the rice-flour group or the resistant-
starch group. Patients were allowed to drink additional water with-
out restriction. Patients who had hypotension at presentation were
rehydrated intravenously over a period of four hours and then en-
rolled in the study. A standard southern Indian vegetarian diet
was provided to all patients, who were encouraged to eat as soon
as possible. A 300-mg dose of doxycycline was administered oral-
ly after 24 hours.
All feces from each patient were collected in buckets lined with
plastic bags and stored at 4°C. Twice a day, the collected feces
were weighed, and aliquots were taken and stored at ¡20°C until
analysis. The collection, weighing, and analysis of the feces were
carried out by one of the investigators, who was unaware of the
treatment that the patient was receiving. Fluid intake and urine
output were monitored every six hours. Serum electrolytes, urea
nitrogen, and creatinine were measured daily. Fecal collection was
continued for 48 hours, and patients were hospitalized until the
consistency of the stool returned to normal. Stool consistency was
graded as watery, semi-loose, semi-formed, mushy, or solid. The
timing of each stool was noted. The duration of diarrhea was ar-
bitrarily defined as the period from the start of oral hydration un-
til the first mushy or formed stool.
 
Transit and Fermentation Studies
 
In six additional patients with cholera, 1 liter of oral rehydra-
tion solution with glucose that contained 50 g of amylase-resist-
ant starch and 2 g of polyethylene glycol with an average molec-
ular weight of 4000 (PEG 4000, Fluka, Buchs, Switzerland) was
instilled into the stomach through a nasogastric tube. All feces were
collected and monitored for the presence of polyethylene glycol,
glucose, and starch. The patients received fluids intravenously and
were not permitted to eat or drink for 12 hours. After 12 hours,
patients again received therapy with oral hydration and were per-
mitted to eat and drink.
 
Chemical and Biochemical Analyses
 
Fecal starch was measured enzymatically with a starch-assay kit
(Total Starch Assay Procedure, Megazyme, Warriewood, Australia).
Fecal glucose was measured enzymatically with glucose oxidase.
Fecal polyethylene glycol was measured by turbidimetry.
 
21
 
Statistical Analysis
 
All values are expressed as means ±SD. We measured the sig-
nificance of differences between groups using two-sample t-tests
or Mann–Whitney U tests, as appropriate. All P values are two-
tailed. P values of 0.05 or less were considered to indicate statis-
tical significance.
 
RESULTS
 
Patients enrolled in the three groups did not differ
significantly with regard to demographic character-
istics (Table 1). None of the patients in the study
had coexisting medical illness, except one assigned
to standard therapy, who had extrahepatic portal hy-
pertension with no history of gastrointestinal bleed-
ing or evidence of ascites or liver dysfunction. All pa-
tients enrolled completed the study.
 
Fecal Weight
 
Table 2 lists the mean fecal weight in the three
treatment groups during four consecutive 12-hour
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periods that began at enrollment. Fecal weight dur-
ing the periods from 0 to 12 hours, 12 to 24 hours,
and 24 to 36 hours after enrollment for patients treat-
ed with the rice-flour therapy was not significantly
different from that for patients treated with standard
therapy. However, during the period from 36 to 48
hours, fecal weight was significantly lower in the rice-
flour group than in the standard-therapy group (P=
0.05). In the resistant-starch group, the fecal weight
was similar to that in the other two groups in the
first 12 hours but was significantly lower than the
weight in the standard-therapy group during the pe-
riods from 12 to 24 hours, 24 to 36 hours, and 36
to 48 hours after enrollment and was significantly
lower than that in the rice-flour group during the
36-to-48-hour period.
 
Time to the First Formed Stool
 
The length of time to the first formed stool was a
mean of 90.9±29.8 hours among the patients treat-
ed with standard therapy but was significantly short-
er among the patients in the rice-flour group (70.8±
 
*Plus–minus values are means ±SD.
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Figure 1.
 
 The Effect on the Time to the First Formed Stool of
Adding Rice Flour and Resistant Starch to Standard Oral Rehy-
dration Solution.
The values shown are means (±SD) for 16 patients in each
group. Stool consistency was characterized as watery, semi-
loose, semi-formed, mushy, or solid. A formed stool was de-
fined as either mushy or solid. The time to the first formed stool
was significantly shorter in the resistant-starch group than in
the standard-therapy group (P=0.001) or the rice-flour group
(P=0.05), and it was significantly shorter in the rice-flour group
than in the standard-therapy group (P=0.03).
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Figure 2.
 
 The Effect on Fecal Starch Excretion of Adding Rice
Flour and Resistant Starch to Standard Oral Rehydration So-
lution.
The values shown are means (±SD) for 16 patients in each group.
The amounts of fecal starch excreted are the sums of four 12-
hour periods. Excretion was significantly higher in the resist-
ant-starch group than in the standard-therapy group (P=0.002)
or the rice-flour group (P=0.01).
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20.2 hours, P=0.03). The time to the first formed
stool in the resistant-starch group (56.7±18.6 hours)
was significantly shorter than in either the standard-
therapy group (P=0.001) or the rice-flour group
(P=0.05) (Fig. 1).
 
Fecal Starch
 
The total amount of starch excreted in feces over
a period of 48 hours was significantly higher in the
resistant-starch group (32.6±30.4 g) than in either
the standard-therapy group (11.7±4.1 g, P=0.002)
or the rice-flour group (15.1±8.4 g, P=0.01) (Fig.
2). Glucose was recovered in only negligible quanti-
ties from the feces in all groups, and the amount did
not differ significantly between the groups.
 
Transit of Starch from Stomach to Stool
 
As shown in Table 3, total fecal recovery of poly-
ethylene glycol was 95±10 percent, and none was
recovered after 12 hours. After the instillation of am-
ylase-resistant starch into the stomach, substantial
quantities were recovered from feces, an average of
16.6 percent of the amount instilled. Free glucose
was recovered in negligible quantities.
 
DISCUSSION
 
There have been many attempts to improve the
characteristics of oral rehydration solution so that it
reduces fecal fluid loss and the duration of diarrhea.
Most attempts have focused on the enhancement of
small-bowel absorption of fluids through the use of
amino acids or hypo-osmolar solutions.
 
11
 
 In the pres-
ent study, we took a different approach: we tested
whether the addition of ingredients that improved co-
lonic absorption (without altering osmolality) would
reduce the output of stools and the duration of di-
arrhea in adolescent and adult patients with cholera.
Our findings indicate that the duration of diarrhea
was significantly shortened, and the loss of fluid in
stools considerably reduced, when resistant starch
was administered in addition to the standard oral re-
hydration solution and when patients were encour-
aged to eat as soon as possible after the administra-
tion of the solution.
The use of cereal-based oral rehydration therapy
in patients with cholera
 
22
 
 and rice-derived glucose
polymer in infants with diarrhea (predominantly those
with rotavirus infection)
 
23
 
 significantly reduced stool
output. These clinical benefits stem from the in-
creased absorption of sodium and water.
 
11
 
 Although
the hypo-osmolality of cereal-based solutions has been
considered critical to the absorption of sodium and
water,
 
11
 
 other possible factors include a kinetic ad-
vantage of such solutions that results from the jux-
taposition of hydrolytic and absorptive sites in the
small intestine, enhancement of mucosal repair by
luminal nutrients, and a specific antisecretory factor
in rice. It is possible that some of these effects may
contribute to the benefit of amylase-resistant starch,
because some of the starch is digested in the small
intestine.
Not considered in previous explanations of the ef-
ficacy of cereal-based oral rehydration therapy in re-
ducing fecal fluid loss was the possibility of enhanced
colonic absorption through the formation of short-
chain fatty acids.
 
24
 
 The ability of the colon to absorb
sodium against substantial electrochemical gradients
and its considerable reserve capacity to absorb fluid
are important determinants of fluid loss from diar-
rhea.
 
13
 
 In cholera, the reserve capacity of the colon
is impaired.
 
14
 
 Short-chain fatty acids are a potent
stimulus for the colonic absorption of sodium and
water from both the normal and the secreting co-
lon.
 
25-27 
 
Sodium absorption that is linked to short-
chain fatty acids is not inhibited by cyclic nucleotides
 
20
 
and is up-regulated by the action of cholera toxin in
the colons of laboratory animals.
 
28
 
 Thus, such sodium
absorption from the colon is analogous to glucose-
linked sodium absorption from the small intestine,
which is also up-regulated by cyclic nucleotides.
 
29
 
Cereals contain complex carbohydrates classified
as either nonstarch polysaccharides or starch.16 The
starch in cereals is only partly digested in the small
bowel; the proportion that is resistant to digestion
depends on genetic factors (as in high-amylose maize)
as well as physical aspects of the cooking and proc-
essing.17 When starch enters the colon, it is rapidly
fermented, resulting in a higher proportion of bu-
tyrate relative to other short-chain fatty acids than is
the case with other fermentation substrates.30 Bu-
*The values shown are means ±SD.
TABLE 3. CUMULATIVE FECAL RECOVERY OF POLYETHYLENE GLYCOL AND STARCH 
FROM SIX ADDITIONAL PATIENTS IN WHOM 1 LITER OF ORAL REHYDRATION SOLUTION
THAT CONTAINED 50 g OF RESISTANT STARCH AND 2 g OF POLYETHYLENE GLYCOL 
WAS INSTILLED INTO THE STOMACH.*
SUBSTANCE 1 HR 2 HR 3 HR 4 HR 5 HR 6 HR 12 HR
Polyethylene glycol (g) 0.1±0.1 0.2±0.2 0.6±0.2 1.1±0.1 1.5±0.1 1.7±0.1 1.9±0.2
Starch (g) 0.1±0.0 0.1±0.1 1.8±1.8 3.2±3.2 5.9±6.6 7.4±8.0 8.3±8.9
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tyrate is the most effective of the three most abundant
short-chain fatty acids in stimulating sodium absorp-
tion in the colon.26
In the present study, the decreases in fecal weight
and the time to the first formed stool that resulted
from resistant-starch therapy were probably the re-
sult of fermentation of the resistant starch by colonic
bacteria, with conversion to short-chain fatty acids,
which then enhanced absorption of fluids and elec-
trolytes in the colon. The excretion of fecal starch was
significantly higher in patients who received the re-
sistant-starch therapy than in patients who received
the rice-flour or standard therapy.
On average, only 16.6 percent of a bolus dose of
resistant starch administered in the stomach was re-
covered in the feces. Because more than 50 percent of
uncooked amylase-resistant starch is resistant to diges-
tion, it appears likely that more than 50 percent of
the starch that reached the colon was metabolized
to short-chain fatty acids, which were rapidly absorbed
by colonic epithelial cells. Because neither the con-
centration nor the output of short-chain fatty acids in
feces necessarily reflects their production, it is difficult
to estimate production. In the present study, between
24 and 36 hours after enrollment, concentrations of
short-chain fatty acids in feces were higher with re-
sistant-starch therapy (16.2±11.8 mEq) than with
standard therapy (8.0±10.2 mEq, P=0.04) or rice-
flour therapy (8.0±8.0 mEq, P=0.03). This increase
may result, in part, from reduced fecal excretion of wa-
ter. However, the total fecal output of short-chain fatty
acids during the third and fourth 12-hour periods of
the study showed a trend toward greater output in the
resistant-starch group (64.5±56.7 mEq) than in the
standard-therapy group (35.0±19.6 mEq, P=0.06)
and the rice-flour group (35.9±19.6 mEq, P=0.07).
The use of oral rehydration solution, along with
the encouragement of patients to begin eating as soon
as possible, is highly effective for correcting fluid and
electrolyte losses in diarrhea. However, many factors
have impeded the widespread acceptance of oral re-
hydration therapy, including the fact that there is con-
tinued fecal fluid loss and continued diarrhea after
this therapy begins.8,9 The present study shows that
in adolescent and adult patients with cholera, resist-
ant starch, when added to oral rehydration solution,
can successfully reduce fecal fluid loss and shorten
the duration of diarrhea. Caution must be used in ex-
trapolating the results for cholera to noncholera di-
arrhea, however. A meta-analysis of studies of cereal-
based oral rehydration solutions showed that these
solutions reduced fecal volume by 32 to 36 percent
in patients with cholera, but only by about 18 percent
in patients with diarrhea not caused by cholera.22 It
is possible that the incorporation of substrate into
oral rehydration solutions to promote fermentation
in the colon would decrease fecal volume and the
duration of illness in diarrhea not associated with
cholera. Such a solution could then be used univer-
sally for most diarrheal diseases.
Supported by a grant from the Nestlé Foundation, Lausanne, Switzer-
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REFERENCES
1. Bern C, Martines J, de Zoysa I, Glass RI. The magnitude of the global 
problem of diarrhoeal disease: a ten-year update. Bull World Health Organ 
1992;70:705-14.
2. Water with sugar and salt. Lancet 1978;2:300-1.
3. Carpenter CCJ. The treatment of cholera: clinical science at the bedside. 
J Infect Dis 1992;166:2-14.
4. Babaniyi OA. Oral rehydration of children with diarrhoea in Nigeria: 
a 12-year review of impact on morbidity and mortality from diarrhoeal 
diseases and diarrhoeal treatment practices. J Trop Pediatr 1991;37:57-
63.
5. Pierre-Louis JN. Oral rehydration program evaluation by quality assur-
ance sampling in rural Haiti. Am J Public Health 1991;81:1205-7.
6. Behrens RH. The impact of oral rehydration and other therapies on the 
management of acute diarrhoea. Trans R Soc Trop Med Hyg 1993;87:
(Suppl 3):S3/35-S3/38.
7. Reis EC, Goepp JG, Katz S, Santosham M. Barriers to use of oral rehy-
dration therapy. Pediatrics 1994;93:708-11.
8. Greenough WB III. A simple solution: curing diarrhea. J Diarrhoeal 
Dis Res 1993;11:1-5.
9. Desjeux JF, Briend A, Butzner JD. Oral rehydration solution in the year 
2000: pathophysiology, efficacy and effectiveness. Baillieres Clin Gastroen-
terol 1997;11:509-27.
10. Meeuwisse GW. High sugar worse than high sodium in oral rehydra-
tion solutions. Acta Paediatr Scand 1983;72:161-6.
11. Thillainayagam AV, Hunt JB, Farthing MJG. Enhancing clinical effica-
cy of oral rehydration therapy: is low osmolality the key? Gastroenterology 
1998;114:197-210.
12. Binder HJ, Sandle GI, Rajendran VM. Colonic fluid and electrolyte 
transport in health and disease. In: Phillips SF, Pemberton JH, Shorter RG, 
eds. The large intestine: physiology, pathophysiology, and disease. New 
York: Raven Press, 1991:141-68.
13. Read NW. Diarrhoea: the failure of colonic salvage. Lancet 1982;2:
481-3.
14. Speelman P, Butler T, Kabir I, Ali A, Banwell J. Colonic dysfunction 
during cholera infection. Gastroenterology 1986;91:1164-70.
15. Ramakrishna BS, Mathan VI. Colonic dysfunction in acute diarrhoea: 
the role of luminal short chain fatty acids. Gut 1993;34:1215-8.
16. Cummings JH, Englyst HN. Fermentation in the human large intes-
tine and the available substrates. Am J Clin Nutr 1987;45:1243-55.
17. Brown I. Complex carbohydrates and resistant starch. Nutr Rev 1996;
54:S115-S119.
18. Phillips J, Muir JG, Birkett A, Lu ZX, Young GP, O’Dea K. Effect of 
resistant starch on fecal bulk and fermentation-dependent events in hu-
mans. Am J Clin Nutr 1995;61:1-10.
19. Muir JG, Lu ZX, Young GP, Cameron-Smith D, Collier GR, O’Dea 
K. Resistant starch in the diet increases breath hydrogen and serum acetate 
in human subjects. Am J Clin Nutr 1995;61:792-9.
20. Binder HJ, Mehta P. Characterization of butyrate-dependent electro-
neutral Na-Cl absorption in the rat distal colon. Pflugers Arch 1990;417:
365-9.
21. Hyden S. A turbidimetric method for the determination of higher 
polyethylene glycols in biological materials. Ann R Agric Coll Sweden 
1955;22:139-45.
22. Gore SM, Fontaine O, Pierce NF. Impact of rice based oral rehydration 
solution on stool output and duration of diarrhoea: meta-analysis of 13 
clinical trials. BMJ 1992;304:287-91.
23. Pizarro D, Posada G, Sandi L, Moran JR. Rice-based oral electrolyte 
solutions for the management of infantile diarrhea. N Engl J Med 1991;
324:517-21. [Erratum, N Engl J Med 1992;326:488-9.]
24. Binder HJ, Ramakrishna BS. Resistant starch and SCFA: adjunct to 
ORS? Gastroenterology 1998;115:512.
25. Ruppin H, Bar-Meir S, Soergel KH, Wood CM, Schmitt MG Jr. Ab-
sorption of short-chain fatty acids by the colon. Gastroenterology 1980;
78:1500-7.
26. Binder HJ, Mehta P. Short-chain fatty acids stimulate active sodium 
and chloride absorption in vitro in the rat distal colon. Gastroenterology 
1989;96:989-96.
27. Ramakrishna BS, Nance SH, Roberts-Thomson IC, Roediger WEW. 
The effects of enterotoxins and short-chain fatty acids on water and elec-
The New England Journal of Medicine 
Downloaded from nejm.org on May 13, 2011. For personal use only. No other uses without permission. 
 Copyright © 2000 Massachusetts Medical Society. All rights reserved. 
AMYLASE-RESISTANT STARCH PLUS ORAL REHYDRATION SOLUTION FOR CHOLERA
Volume 342 Number 5 · 313
trolyte fluxes in ileal and colonic loops in vivo in the rat. Digestion 1990;
45:93-101.
28. Krishnan S, Ramakrishna BS, Binder HJ. Stimulation of sodium chlo-
ride absorption from secreting rat colon by short-chain fatty acids. Dig Dis 
Sci 1999;44:1924-30.
29. Nath SK, Rautureau M, Heyman M, Reggio H, L’Helgoualc’h A, 
Desjeux JF. Emergence of Na+-glucose cotransport in an epithelial secre-
tory cell line sensitive to cholera toxin. Am J Physiol 1989;256:G335-
G341.
30. Scheppach W, Fabian C, Sachs M, Kasper H. The effect of starch mal-
absorption on fecal short-chain fatty acid excretion in man. Scand J Gas-
troenterol 1988;23:755-9.
The New England Journal of Medicine 
Downloaded from nejm.org on May 13, 2011. For personal use only. No other uses without permission. 
 Copyright © 2000 Massachusetts Medical Society. All rights reserved. 
